223 related articles for article (PubMed ID: 29392648)
21. Cancer Precision-Prevention trial of Metformin in adults with Li Fraumeni syndrome (MILI) undergoing yearly MRI surveillance: a randomised controlled trial protocol.
Dixon-Zegeye M; Shaw R; Collins L; Perez-Smith K; Ooms A; Qiao M; Pantziarka P; Izatt L; Tischkowitz M; Harrison RE; George A; Woodward ER; Lord S; Hawkes L; Evans DG; Franklin J; Hanson H; Blagden SP
Trials; 2024 Feb; 25(1):103. PubMed ID: 38308321
[TBL] [Abstract][Full Text] [Related]
22. Association Between the Oligomeric Status of p53 and Clinical Outcomes in Li-Fraumeni Syndrome.
Fischer NW; Prodeus A; Tran J; Malkin D; Gariépy J
J Natl Cancer Inst; 2018 Dec; 110(12):1418-1421. PubMed ID: 29955864
[TBL] [Abstract][Full Text] [Related]
23. Evolution of germline TP53 variant classification in children with cancer.
Tallis E; Scollon S; Ritter DI; Plon SE
Cancer Genet; 2022 Jun; 264-265():29-32. PubMed ID: 35306447
[TBL] [Abstract][Full Text] [Related]
24. Upper Gastrointestinal Cancer Risk and Surveillance Outcomes in Li-Fraumeni Syndrome.
Katona BW; Powers J; McKenna DB; Long JM; Le AN; Hausler R; Zelley K; Jennings S; Domchek SM; Nathanson KL; MacFarland SP; Maxwell KN
Am J Gastroenterol; 2020 Dec; 115(12):2095-2097. PubMed ID: 32969947
[TBL] [Abstract][Full Text] [Related]
25. Clinical management of TP53 mosaic variants found on germline genetic testing.
Ward A; Farengo-Clark D; McKenna DB; Safonov A; Good M; Le A; Kessler L; Shah PD; Bradbury AR; Domchek SM; Nathanson KL; Powers J; Maxwell KN
Cancer Genet; 2024 Jun; 284-285():43-47. PubMed ID: 38677009
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of
Schwartz AN; Hyman SR; Stokes SM; Castillo D; Tung NM; Weitzel JN; Rana HQ; Garber JE
JCO Precis Oncol; 2021 Nov; 5():1677-1686. PubMed ID: 34994652
[TBL] [Abstract][Full Text] [Related]
27. Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variants.
de Andrade KC; Strande NT; Kim J; Haley JS; Hatton JN; Frone MN; Khincha PP; Thone GM; Mirshahi UL; Schneider C; Desai H; Dove JT; Smelser DT; ; ; Levine AJ; Maxwell KN; Stewart DR; Carey DJ; Savage SA
HGG Adv; 2024 Jan; 5(1):100242. PubMed ID: 37777824
[TBL] [Abstract][Full Text] [Related]
28. TP53, MSH4, and LATS1 germline mutations in a family with clustering of nervous system tumors.
Kim YH; Ohta T; Oh JE; Le Calvez-Kelm F; McKay J; Voegele C; Durand G; Mittelbronn M; Kleihues P; Paulus W; Ohgaki H
Am J Pathol; 2014 Sep; 184(9):2374-81. PubMed ID: 25041856
[TBL] [Abstract][Full Text] [Related]
29. Phenotype analysis of families with TP53 germline variants at the Center for Familial Breast and Ovarian Cancer, Cologne.
Kast K; Rhiem K; Larsen M; Wappenschmidt B; Schmutzler R
Cancer Med; 2024 Feb; 13(3):e6920. PubMed ID: 38230850
[TBL] [Abstract][Full Text] [Related]
30. The Clinical and Molecular Profile of Lung Cancer Patients Harboring the
Lopes CDH; Antonacio FF; Moraes PMG; Asprino PF; Galante PAF; Jardim DL; de Macedo MP; Sandoval RL; Katz A; de Castro G; Achatz MI
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894716
[TBL] [Abstract][Full Text] [Related]
31. Frequency of Radiation Therapy-Induced Malignancies in Patients With Li-Fraumeni Syndrome and Early-Stage Breast Cancer and the Influence of Radiation Therapy Technique.
Petry V; Bonadio RC; Moutinho K; Leite LS; Testa L; Cohn DJBH; Cagnacci AC; Kim VEH; Del Pilar Estevez-Diz M; Fragoso MCBV
Int J Radiat Oncol Biol Phys; 2024 Jul; 119(4):1086-1091. PubMed ID: 38309330
[TBL] [Abstract][Full Text] [Related]
32. Endometrial Carcinoma as the Presenting Malignancy in a Teenager With a Pathogenic TP53 Germline Mutation: A Case Report and Literature Review.
Irshaid L; Clark M; Fadare O; Finberg KE; Parkash V
Int J Gynecol Pathol; 2022 May; 41(3):258-267. PubMed ID: 33990091
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of Li-Fraumeni Syndrome in Japan; A Review Study by the Special Committee of JSHT.
Funato M; Tsunematsu Y; Yamazaki F; Tamura C; Kumamoto T; Takagi M; Kato S; Sugimura H; Tamura K
Cancer Sci; 2021 May; 112(7):2821-34. PubMed ID: 33932062
[TBL] [Abstract][Full Text] [Related]
34. Surveillance imaging and early surgical intervention for improved CNS tumor outcomes in children with Li-Fraumeni syndrome: Children's National Hospital experience and literature review.
Patel N; Felton K; Bhattacharya S; Almira-Suarez MI; Eze A; Turner J; Keating R; Oluigbo C; Schore RJ; Kilburn L; Packer RJ; Myseros JS; Bornhorst M
J Neurosurg Pediatr; 2023 Mar; 31(3):258-267. PubMed ID: 36609372
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.
Kolodziejczak AS; Guerrini-Rousseau L; Planchon JM; Ecker J; Selt F; Mynarek M; Obrecht D; Sill M; Autry RJ; Stutheit-Zhao E; Hirsch S; Amouyal E; Dufour C; Ayrault O; Torrejon J; Waszak SM; Ramaswamy V; Pentikainen V; Demir HA; Clifford SC; Schwalbe EC; Massimi L; Snuderl M; Galbraith K; Karajannis MA; Hill K; Li BK; Walsh M; White CL; Redmond S; Loizos L; Jakob M; Kordes UR; Schmid I; Hauer J; Blattmann C; Filippidou M; Piccolo G; Scheurlen W; Farrag A; Grund K; Sutter C; Pietsch T; Frank S; Schewe DM; Malkin D; Ben-Arush M; Sehested A; Wong TT; Wu KS; Liu YL; Carceller F; Mueller S; Stoller S; Taylor MD; Tabori U; Bouffet E; Kool M; Sahm F; von Deimling A; Korshunov A; von Hoff K; Kratz CP; Sturm D; Jones DTW; Rutkowski S; van Tilburg CM; Witt O; Bougeard G; Pajtler KW; Pfister SM; Bourdeaut F; Milde T
Neuro Oncol; 2023 Dec; 25(12):2273-2286. PubMed ID: 37379234
[TBL] [Abstract][Full Text] [Related]
36. The African-centric P47S Variant of
Stieg DC; Parris JLD; Yang THL; Mirji G; Reiser SK; Murali N; Werts M; Barnoud T; Lu DY; Shinde R; Murphy ME; Claiborne DT
Cancer Res Commun; 2023 Jul; 3(7):1200-1211. PubMed ID: 37441266
[TBL] [Abstract][Full Text] [Related]
37. De novo germline TP53 mutation in a pediatric patient with Li-Fraumeni syndrome and diffuse peritoneal mesothelioma.
Ortaköylü MY; Özdemir Sİ; Dinçaslan H; Taçyıldız N; Ateş U; Ünal AE; Soydal Ç; Fitoz ÖS; Karabulut HG; Ruhi HI; Ünal EC
Pediatr Blood Cancer; 2024 Aug; 71(8):e31071. PubMed ID: 38773723
[No Abstract] [Full Text] [Related]
38. Genetic and stochastic influences upon tumor formation and tumor types in Li-Fraumeni mouse models.
Chan CS; Sun Y; Ke H; Zhao Y; Belete M; Zhang C; Feng Z; Levine AJ; Hu W
Life Sci Alliance; 2021 Mar; 4(3):. PubMed ID: 33376133
[No Abstract] [Full Text] [Related]
39. A Novel Germline TP53 Mutation in a Patient With Li-Fraumeni Syndrome: Resolving a Variant of Uncertain Significance.
Douglass DP; Stine KC; Farrar JE
J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1220-e1222. PubMed ID: 33633026
[TBL] [Abstract][Full Text] [Related]
40. Early Cancer Detection in Li-Fraumeni Syndrome with Cell-Free DNA.
Wong D; Luo P; Oldfield LE; Gong H; Brunga L; Rabinowicz R; Subasri V; Chan C; Downs T; Farncombe KM; Luu B; Norman M; Sobotka JA; Uju P; Eagles J; Pedersen S; Wellum J; Danesh A; Prokopec SD; Stutheit-Zhao EY; Znassi N; Heisler LE; Jovelin R; Lam B; Lujan Toro BE; Marsh K; Sundaravadanam Y; Torti D; Man C; Goldenberg A; Xu W; Veit-Haibach P; Doria AS; Malkin D; Kim RH; Pugh TJ
Cancer Discov; 2024 Jan; 14(1):104-119. PubMed ID: 37874259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]